Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

5-hydroxytryptamine selective antagonists

N-methyl-actinodaphnine possesses 5-hydroxytryptamine receptor blocking activity and a selective antagonist of cq-adrenoceptors, selective for the a1B. than for the a1A-adrenoceptor subtype (14). What are the activities of N-methyl-actinodaphnine and other aporphines of Illigera and Hernandia species against topoisomerase ... [Pg.178]

MDL 73147EF) is a substituted quinolizinylindole, a selective (5-HT3) 5-hydroxytryptamine receptor antagonist. It shows ANTIEMETIC activity against chemotherapy-induced emesis, and also has antimigraine activity, dolasetron mesylate dolasetron. [Pg.103]

Palfium dextromoramide. palmidrol [inn] is a lipid compound isolated from soyabean lecithin, egg yolk and peanut meal. It has IMMUNOMODULATOR and ANTliNFlAMMATORY properties, palonosetron [inn] (palonosetron hydrochloride [usan] RS 42358) is a benzisoquinolinone derivative, a selective (5-HT]) 5-hydroxytryptamine receptor antagonist, with ANTIEMETIC and anxiolytic activity, palonosetron hydrochloride palonosetron. PalUdrine proguanil. [Pg.213]

SB 204070 is a benzodioxane, and acts as a selective (5-HT4) 5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONIST. It has been used as a pharmacological tool In the Investigation of normal and disturbed gastrointestinal activity. [Pg.253]

The compound [ la(Z),2, 5a]-methyl-7-[2-(4-morpholinyl)-3-oxo-5-(phenyl-methoxy)cyclopentyl]-5-heptenoate (AH 19437) inhibited platelet aggregation and 5-hydroxytryptamine release without inhibiting fatty acid cyclo-oxygenase, thromboxane synthetase, cAMP phosphodiesterase or prostacyclin synthetase, consistent with the view that AH 19437 is a selective antagonist of platelet TXAj receptors [254-256],... [Pg.69]

Serotonin (5-hydroxytryptamine 5-HT) acts as transmitter and mediator on several locations in the body with quite different effects. There are multiple sub-types of the serotonin receptor. This offers the possibility of a selective therapeutic interference using subtype specific agonists or antagonists. [Pg.314]

Marek GJ, Aghajanian GK. 1994. Excitation of intemeurons in piriform cortex by 5-hydroxytryptamine Blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. Eur J Pharmacol 259 137-141. [Pg.194]

Ondansetron is a selective, 5-hydroxytryptamine antagonist, nsed to prevent vomiting dnring cancer chemotherapy and radiotherapy. [Pg.418]

See other pages where 5-hydroxytryptamine selective antagonists is mentioned: [Pg.570]    [Pg.44]    [Pg.46]    [Pg.128]    [Pg.183]    [Pg.207]    [Pg.222]    [Pg.82]    [Pg.100]    [Pg.312]    [Pg.739]    [Pg.211]    [Pg.1516]    [Pg.301]    [Pg.264]    [Pg.240]    [Pg.9]    [Pg.399]    [Pg.29]    [Pg.8]    [Pg.92]    [Pg.577]    [Pg.578]    [Pg.180]    [Pg.12]    [Pg.367]    [Pg.521]    [Pg.30]    [Pg.238]    [Pg.617]    [Pg.52]   
See also in sourсe #XX -- [ Pg.68 , Pg.72 ]



SEARCH



1-Hydroxytryptamines

5- Hydroxytryptamine , antagonist

Selective antagonists

© 2024 chempedia.info